Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data

por Mustafa Kürşat Tigen, Mehmet Hasan Özdil, Altuğ Çinçin, Emre Gürel, Murat Sünbül, Anıl Şahin, Tuba Güçtekin, Zekeriya Doğan, Nurten Sayar, Beste Özben
Publicado 2021

Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry

por Mustafa Kemal Erol, Meral Kayıkçıoğlu, Mustafa Kılıçkap, Arda Güler, Önder Öztürk, Burcu Tuncay, Sinan İnci, İsmail Balaban, Fatih Tatar, Ömer Faruk Çırakoğlu, Emine Gazi, Eftal Murat Bakırcı, Çağrı Yayla, Mehmet Ali Astarcıoğlu, Bilge Duran Karaduman, Ekrem Aksu, Yakup Alsancak, Nadir Emlek, Mustafa Kürşat Tigen, Nihan Turhan Cağlar, Ramazan Düz, Mehmet Inanir, Öner Özdoğan, Oğuz Yavuzgil
Publicado 2021